$ZOM
Zomedica Corp.

2024 Q3 Form 10-Q Financial Statement

#000155837024012228 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $6.997M $6.131M $6.020M
YoY Change 10.24% 1.84% 2073.29%
Cost Of Revenue $1.937M $1.769M $1.972M
YoY Change -2.42% -10.29% 62.98%
Gross Profit $5.060M $4.362M $4.048M
YoY Change 16.0% 7.76% 33.33%
Gross Profit Margin 72.32% 71.15% 67.24%
Selling, General & Admin $10.66M $11.90M $9.931M
YoY Change 12.83% 19.82% 15.52%
% of Gross Profit 210.57% 272.79% 245.33%
Research & Development $1.845M $1.506M $859.0K
YoY Change 112.8% 75.32% 169.28%
% of Gross Profit 36.46% 34.53% 21.22%
Depreciation & Amortization $417.0K $351.0K $340.0K
YoY Change -73.87% 3.24% 378.87%
% of Gross Profit 8.24% 8.05% 8.4%
Operating Expenses $12.50M $13.41M $10.79M
YoY Change 21.24% 24.24% 21.02%
Operating Profit -$7.440M -$25.07M -$6.742M
YoY Change 25.08% 271.8% 14.66%
Interest Expense $961.0K $992.0K $62.00K
YoY Change 1401.56% 1500.0% -72.44%
% of Operating Profit
Other Income/Expense, Net -$111.0K $52.00K
YoY Change -105.06%
Pretax Income -$6.724M -$24.07M -$5.326M
YoY Change 178.89% 352.01% -5.82%
Income Tax -$27.00K -$143.0K -$77.00K
% Of Pretax Income
Net Earnings -$6.697M -$23.93M -$5.249M
YoY Change 1263.95% 355.92% -0.46%
Net Earnings / Revenue -95.71% -390.33% -87.19%
Basic Earnings Per Share -$0.01 -$0.02 -$0.01
Diluted Earnings Per Share -$0.01 -$0.02 -$0.01
COMMON SHARES
Basic Shares Outstanding 979.9M 979.9M 979.9M
Diluted Shares Outstanding 979.9M 979.9M 979.9M

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $76.88M $79.51M $130.5M
YoY Change -27.62% -39.06% -30.14%
Cash & Equivalents $9.747M $7.939M $27.95M
Short-Term Investments $67.13M $71.57M $102.5M
Other Short-Term Assets $2.579M $2.100M $3.562M
YoY Change -14.55% -41.04% 53.87%
Inventory $5.429M $5.507M $3.634M
Prepaid Expenses
Receivables $1.759M $1.383M $654.0K
Other Receivables $628.0K $724.0K $1.302M
Total Short-Term Assets $87.27M $89.22M $139.6M
YoY Change -24.37% -36.1% -28.26%
LONG-TERM ASSETS
Property, Plant & Equipment $25.54M $24.98M $7.291M
YoY Change 209.24% 242.6% 326.37%
Goodwill $45.56M $45.56M $63.98M
YoY Change -38.25% -28.8% 47.8%
Intangibles $51.62M $53.22M $48.07M
YoY Change -9.33% 10.71% 49.77%
Long-Term Investments $966.0K $3.482M $11.92M
YoY Change -91.8% -70.79% 1092.0%
Other Assets $1.143M $1.185M $265.0K
YoY Change 34.15% 347.17% 0.0%
Total Long-Term Assets $126.8M $130.7M $135.2M
YoY Change -20.55% -3.33% 67.16%
TOTAL ASSETS
Total Short-Term Assets $87.27M $89.22M $139.6M
Total Long-Term Assets $126.8M $130.7M $135.2M
Total Assets $214.1M $219.9M $274.8M
YoY Change -22.15% -19.98% -0.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.376M $2.323M $6.144M
YoY Change -57.56% -62.19% 76.0%
Accrued Expenses $4.667M $4.370M $74.00K
YoY Change 3993.86% 5805.41% 80.49%
Deferred Revenue $293.0K $271.0K $255.0K
YoY Change 14.01% 6.27% 66.67%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $641.0K
YoY Change 22.56%
Total Short-Term Liabilities $8.064M $7.835M $7.210M
YoY Change 19.64% 8.67% 61.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $781.0K
YoY Change -100.0% -100.0% -34.04%
Other Long-Term Liabilities $808.0K $736.0K $2.181M
YoY Change -43.61% -66.25% 457.8%
Total Long-Term Liabilities $808.0K $736.0K $2.181M
YoY Change -43.61% -66.25% 457.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.064M $7.835M $7.210M
Total Long-Term Liabilities $808.0K $736.0K $2.181M
Total Liabilities $11.27M $11.16M $15.30M
YoY Change -20.45% -27.03% 65.25%
SHAREHOLDERS EQUITY
Retained Earnings -$210.7M -$204.0M -$148.0M
YoY Change 41.87% 37.82% 15.11%
Common Stock $413.3M $412.8M $408.1M
YoY Change 0.85% 1.15% 3.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $202.8M $208.7M $259.5M
YoY Change
Total Liabilities & Shareholders Equity $214.1M $219.9M $274.8M
YoY Change -22.15% -19.98% -0.25%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$6.697M -$23.93M -$5.249M
YoY Change 1263.95% 355.92% -0.46%
Depreciation, Depletion And Amortization $417.0K $351.0K $340.0K
YoY Change -73.87% 3.24% 378.87%
Cash From Operating Activities -$4.796M -$6.719M -$3.676M
YoY Change 58.44% 82.78% -9.14%
INVESTING ACTIVITIES
Capital Expenditures $1.087M $1.266M $96.00K
YoY Change -88.2% 1218.75% -241.18%
Acquisitions
YoY Change
Other Investing Activities $7.628M $5.038M $23.42M
YoY Change 25.21% -78.49% -1810.52%
Cash From Investing Activities $6.541M $3.772M $23.32M
YoY Change -309.45% -83.83% -1722.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -70.00K
YoY Change
NET CHANGE
Cash From Operating Activities -4.796M -6.719M -3.676M
Cash From Investing Activities 6.541M 3.772M 23.32M
Cash From Financing Activities -70.00K
Net Change In Cash 1.675M -2.947M 19.64M
YoY Change -127.24% -115.0% -458.29%
FREE CASH FLOW
Cash From Operating Activities -$4.796M -$6.719M -$3.676M
Capital Expenditures $1.087M $1.266M $96.00K
Free Cash Flow -$5.883M -$7.985M -$3.772M
YoY Change -51.94% 111.69% -5.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001684144
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
979949668
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
979949668
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38298
dei Entity Registrant Name
EntityRegistrantName
Zomedica Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Phoenix Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 125
dei Entity Address City Or Town
EntityAddressCityOrTown
Ann Arbor
dei Entity Address State Or Province
EntityAddressStateOrProvince
MI
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
48108
dei City Area Code
CityAreaCode
734
dei Local Phone Number
LocalPhoneNumber
369-2555
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Shares
dei Trading Symbol
TradingSymbol
ZOM
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
979949668
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7939000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12952000
CY2024Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
71569000
CY2023Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
77545000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1383000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1197000
CY2024Q2 us-gaap Inventory Net
InventoryNet
5507000
CY2023Q4 us-gaap Inventory Net
InventoryNet
5123000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2100000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2064000
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
724000
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1001000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
89222000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
99882000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
197000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
250000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24979000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22828000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2042000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2466000
CY2024Q2 us-gaap Goodwill
Goodwill
45556000
CY2023Q4 us-gaap Goodwill
Goodwill
61580000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
53218000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
55364000
CY2024Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Noncurrent
DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent
3482000
CY2023Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Noncurrent
DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent
10005000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1185000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
822000
CY2024Q2 us-gaap Assets
Assets
219881000
CY2023Q4 us-gaap Assets
Assets
253197000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2323000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2068000
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
131000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
65000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
740000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
916000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
271000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
276000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4370000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5707000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7835000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9032000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1552000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1814000
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
759000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1138000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
282000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
252000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
736000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
944000
CY2024Q2 us-gaap Liabilities
Liabilities
11164000
CY2023Q4 us-gaap Liabilities
Liabilities
13180000
CY2024Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
979949668
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
979949668
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
380973000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
380973000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
31832000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
29929000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-204024000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-170933000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-64000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
48000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
208717000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
240017000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
219881000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
253197000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6131000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6020000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12393000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11502000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
1769000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
1972000
us-gaap Cost Of Revenue
CostOfRevenue
3914000
us-gaap Cost Of Revenue
CostOfRevenue
3619000
CY2024Q2 us-gaap Gross Profit
GrossProfit
4362000
CY2023Q2 us-gaap Gross Profit
GrossProfit
4048000
us-gaap Gross Profit
GrossProfit
8479000
us-gaap Gross Profit
GrossProfit
7883000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7976000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6850000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16601000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13863000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1506000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
859000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3277000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1777000
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3923000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3081000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8030000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6497000
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
16024000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
16024000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-25067000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6742000
us-gaap Operating Income Loss
OperatingIncomeLoss
-35453000
us-gaap Operating Income Loss
OperatingIncomeLoss
-14254000
CY2024Q2 us-gaap Investment Income Net
InvestmentIncomeNet
1038000
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
1460000
us-gaap Investment Income Net
InvestmentIncomeNet
2131000
us-gaap Investment Income Net
InvestmentIncomeNet
2872000
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
62000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
112000
CY2024Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-51000
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-39000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
52000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
136000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-46000
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
17000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-175000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24074000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5326000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33400000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11503000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-143000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-77000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-309000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
131000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-23931000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5249000
us-gaap Net Income Loss
NetIncomeLoss
-33091000
us-gaap Net Income Loss
NetIncomeLoss
-11634000
CY2024Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
9000
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-8000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
275000
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-58000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-47000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-110000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-44000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23980000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5304000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33203000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11403000
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
979949668
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
979949668
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
979949668
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
979949668
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.024
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.005
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.034
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.012
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
231895000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
859000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
57000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-23931000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-49000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
208717000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
240017000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1960000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
57000
us-gaap Net Income Loss
NetIncomeLoss
-33091000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-112000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
208717000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
263058000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1725000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5249000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-55000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
259479000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
267392000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3490000
us-gaap Net Income Loss
NetIncomeLoss
-11634000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
231000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
259479000
us-gaap Net Income Loss
NetIncomeLoss
-33091000
us-gaap Net Income Loss
NetIncomeLoss
-11634000
us-gaap Depreciation
Depreciation
685000
us-gaap Depreciation
Depreciation
340000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3223000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2492000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
16024000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-39000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000
us-gaap Share Based Compensation
ShareBasedCompensation
1960000
us-gaap Share Based Compensation
ShareBasedCompensation
3490000
zom Non Cash Portion Of Rent Benefit Expense
NonCashPortionOfRentBenefitExpense
14000
zom Non Cash Portion Of Rent Benefit Expense
NonCashPortionOfRentBenefitExpense
5000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
1112000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
1247000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-75000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-379000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
652000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1561000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-10000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-297000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
187000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
52000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-412000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-14000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
148000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
331000
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
66000
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-114000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1333000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-851000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
25000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
157000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-208000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
409000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14309000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7933000
zom Proceeds From Payments For Securities Matured Purchase Of Securities
ProceedsFromPaymentsForSecuritiesMaturedPurchaseOfSecurities
13463000
zom Proceeds From Payments For Securities Matured Purchase Of Securities
ProceedsFromPaymentsForSecuritiesMaturedPurchaseOfSecurities
17178000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
437000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
1750000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3559000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2833000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
70000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
4066000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9397000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8529000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4912000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
596000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-101000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-44000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12952000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27399000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7939000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27951000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
275000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
62000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
27000
zom Transfer Of Property And Equipment Into Intangibles
TransferOfPropertyAndEquipmentIntoIntangibles
1007000
zom Transfer Of Property And Equipment Into Intangibles
TransferOfPropertyAndEquipmentIntoIntangibles
1219000
zom Transfer Of Inventory Into Property And Equipment
TransferOfInventoryIntoPropertyAndEquipment
261000
zom Transfer Of Inventory Into Property And Equipment
TransferOfInventoryIntoPropertyAndEquipment
668000
us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
1274000
us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
1589000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;font-style:italic;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Estimates and Assumptions</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">In preparing these condensed financial statements, management was required to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses.  These estimates and assumptions are based on our historical experience, the terms of existing contracts, our evaluation of trends in the industry, information provided by our customers and suppliers and information available from other outside sources, as appropriate.  These estimates and assumptions are subject to an inherent degree of uncertainty.  We are not presently aware of any events or circumstances that would require us to update such estimates and assumptions or revise the carrying value of our assets or liabilities.  Our estimates may change, however, as new events occur, and additional information is obtained. As a result, actual results may differ significantly from our estimates, and any such differences may be material to our financial statements.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Comparative Figures</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">To provide further clarity on how we present our operating expenses, we have broken down our selling, general and administrative spend into distinct and separate “General and administrative” and “Selling and marketing” line items on the condensed consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2024.  The consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2023 have been adjusted to conform to the current year presentation of operating expenses.  The change in presentation had no effect on the reported results of operations and does not affect previously reported cash flows from operating activities in the consolidated statements of cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">To better align with the way we track our business, we’ve combined construction in progress into property and equipment, net, for the six months ended June 30, 2024.  The consolidated balance sheets for the year ended December 31, 2023 have been adjusted to conform to the current year presentation of property and equipment, net.  The change in presentation had no effect on the reported results in our balance sheets and does not affect previously reported cash flows from investing activities in the consolidated statements of cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">To further enhance the transparency of our financial reporting, we have reclassified “Accounts payable” as its own line item, separating it from “Accounts payable and accrued liabilities.” Furthermore, we combined the accrued liabilities portion of “Accounts payable and accrued liabilities” with amounts previously included in “Other current liabilities” into a new line item, “Accrued expenses and other current liabilities”, to provide a comprehensive view of these obligations as of June 30, 2024. This presentation is supported by the footnote “Accrued Expenses and Other Current Liabilities” in the “Notes to the Condensed Consolidated Financial Statements.” The consolidated balance sheets for the year ended December 31, 2023, have been adjusted to align with the current presentation. The change in presentation had no impact on the reported results in our balance sheets and does not affect previously reported cash flows from operating activities in the consolidated statements of cash flows. Refer to Note 10 for further details.</p>
CY2024Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
392000
CY2023Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1308000
zom Accounts Receivables Payment Term
AccountsReceivablesPaymentTerm
P30D
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
91000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
103000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6131000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6020000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12393000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11502000
CY2024Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
79670000
CY2024Q2 zom Investment Securities Accumulated Accretion Or Amortization
InvestmentSecuritiesAccumulatedAccretionOrAmortization
1139000
CY2024Q2 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
126000
CY2024Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
80683000
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
95367000
CY2023Q4 zom Investment Securities Accumulated Accretion Or Amortization
InvestmentSecuritiesAccumulatedAccretionOrAmortization
1177000
CY2023Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
124000
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
96420000
CY2024Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
451000
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
586000
CY2024Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
79670000
CY2024Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
80683000
CY2024Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
4487000
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
3827000
CY2024Q2 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
556000
CY2023Q4 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
397000
CY2024Q2 zom Inventory Purchase
InventoryPurchase
535000
CY2023Q4 zom Inventory Purchase
InventoryPurchase
948000
CY2024Q2 us-gaap Inventory Gross
InventoryGross
5578000
CY2023Q4 us-gaap Inventory Gross
InventoryGross
5172000
CY2024Q2 us-gaap Inventory Adjustments
InventoryAdjustments
71000
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
49000
CY2024Q2 us-gaap Inventory Net
InventoryNet
5507000
CY2023Q4 us-gaap Inventory Net
InventoryNet
5123000
CY2024Q2 us-gaap Deposit Assets
DepositAssets
261000
CY2023Q4 us-gaap Deposit Assets
DepositAssets
919000
CY2024Q2 us-gaap Prepaid Advertising
PrepaidAdvertising
356000
CY2023Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
259000
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
653000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
436000
CY2024Q2 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
1027000
CY2023Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
700000
CY2024Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
2297000
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
2314000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2526000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4131000
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
911000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1069000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
767000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
145000
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
166000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
362000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4370000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5707000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27593000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24873000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2614000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2045000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24979000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22828000
CY2024Q2 us-gaap Depreciation
Depreciation
351000
CY2023Q2 us-gaap Depreciation
Depreciation
176000
us-gaap Depreciation
Depreciation
685000
us-gaap Depreciation
Depreciation
340000
CY2023Q4 us-gaap Goodwill
Goodwill
61580000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
16024000
CY2024Q2 us-gaap Goodwill
Goodwill
45556000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
16024000
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
66589000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
65511000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13371000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10147000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
53218000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
55364000
CY2024Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
563000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
3216000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
6317000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5852000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5625000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5575000
CY2024Q2 zom Finite Lived Intangible Assets Amortization Expense Year Four And Thereafter
FiniteLivedIntangibleAssetsAmortizationExpenseYearFourAndThereafter
26071000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
52656000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1626000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1293000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3223000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2492000
CY2020Q2 zom Maximum Percentage Of Shares To Be Reserved Under Plan
MaximumPercentageOfSharesToBeReservedUnderPlan
0.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3925000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
8165000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3925000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
8165000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
93349943
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.3338
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3925000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.1452
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2490000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.2350
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
612500
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.7990
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
94172443
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.3255
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
46188274
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.3517
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
84112443
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.3602
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
8165000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.1998
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2095000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.3441
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
727500
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
1.1228
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
89454943
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.3397
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
30045224
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.3497
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
859000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1725000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1960000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3490000
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4298000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
CY2024Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
15524000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6131000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6020000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
1769000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
1972000
CY2024Q2 us-gaap Gross Profit
GrossProfit
4362000
CY2023Q2 us-gaap Gross Profit
GrossProfit
4048000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12393000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11502000
us-gaap Cost Of Revenue
CostOfRevenue
3914000
us-gaap Cost Of Revenue
CostOfRevenue
3619000
us-gaap Gross Profit
GrossProfit
8479000
us-gaap Gross Profit
GrossProfit
7883000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-23931000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5249000
us-gaap Net Income Loss
NetIncomeLoss
-33091000
us-gaap Net Income Loss
NetIncomeLoss
-11634000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
979949668
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
979949668
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
979949668
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
979949668
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.024
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.005
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.034
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.012

Files In Submission

Name View Source Status
0001558370-24-012228-index-headers.html Edgar Link pending
0001558370-24-012228-index.html Edgar Link pending
0001558370-24-012228.txt Edgar Link pending
0001558370-24-012228-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zom-20240630.xsd Edgar Link pending
zom-20240630x10q.htm Edgar Link pending
zom-20240630xex10d3.htm Edgar Link pending
zom-20240630xex10d4.htm Edgar Link pending
zom-20240630xex31d1.htm Edgar Link pending
zom-20240630xex31d2.htm Edgar Link pending
zom-20240630xex32d1.htm Edgar Link pending
zom-20240630_def.xml Edgar Link unprocessable
zom-20240630_lab.xml Edgar Link unprocessable
zom-20240630_pre.xml Edgar Link unprocessable
zom-20240630x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
zom-20240630_cal.xml Edgar Link unprocessable